PetIQ, Inc. (NASDAQ: PETQ) reported Q4 EPS of ($0.49), $0.51 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $196.6 million versus the consensus estimate of $169.68 million.

GUIDANCE:

PetIQ, Inc. sees FY2022 revenue of $985 million, versus the consensus of $981 million.

• Net sales of approximately $985 million representing an increase of 5.6% compared to 2021. For comparative purposes, the Company expects net sales to increase approximately 10.0% excluding $36.1 million of sales related to loss of distribution rights for certain animal health manufacturing products, previously communicated the last few quarters.
• Adjusted EBITDA of approximately $100 million representing an increase of 7.6% compared to 2021. For comparative purposes, the Company expects adjusted EBITDA to increase approximately 10.0%, excluding $1.8 million in adjusted EBITDA related to loss of distribution rights for certain animal health manufacturing products, previously communicated the last few quarters.

For earnings history and earnings-related data on PetIQ, Inc. (PETQ) click here.